Baker Carolyn I, Barrozo Christopher P, Ryan Margaret A K, Pearse Lisa A, Russell Kevin L
Department of Defense Center for Deployment Health Research, Naval Health Research Center, San Diego, California, USA.
BMC Infect Dis. 2005 May 19;5:38. doi: 10.1186/1471-2334-5-38.
In December 2001, a fatal case of pneumococcal meningitis in a Marine Corps recruit was identified. As pneumococcal vaccine usage in recruit populations is being considered, an investigation was initiated into the causative serotype.
Traditional and molecular methods were utilized to determine the serotype of the infecting pneumococcus. The pneumococcal isolate was identified as serotype 38 (PS38), a serotype not covered by current vaccine formulations. The global significance of this serotype was explored in the medical literature, and found to be a rare but recognized cause of carriage and invasive disease.
The potential of PS38 to cause severe disease is documented in this report. Current literature does not support the hypothesis that this serotype is increasing in incidence. However, as we monitor the changing epidemiology of pneumococcal illness in the US in this conjugate era, PS38 might find a more prominent and concerning niche as a replacement serotype.
2001年12月,一名海军陆战队新兵死于肺炎球菌性脑膜炎。鉴于正在考虑在新兵群体中使用肺炎球菌疫苗,因此对致病血清型展开了调查。
采用传统方法和分子方法确定感染肺炎球菌的血清型。该肺炎球菌分离株被鉴定为38型(PS38),这是目前疫苗配方未涵盖的血清型。在医学文献中探讨了该血清型的全球意义,发现它是携带和侵袭性疾病的一种罕见但已被认可的病因。
本报告记录了PS38导致严重疾病的可能性。目前的文献并不支持该血清型发病率正在上升这一假设。然而,在这个结合疫苗时代,随着我们监测美国肺炎球菌疾病不断变化的流行病学情况,PS38作为替代血清型可能会占据更突出且令人担忧的位置。